DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo


company name or ticker

Relative Strength Alert For Tesaro

Should You Buy Tesaro After Its Earnings Miss?

Tesaro just missed earnings estimates by $0.37 per share for its first quarter. Is this stock a bad news buy?

TESARO's (TSRO) CEO Lonnie Moulder on Q1 2014 Earnings - Call Transcript

TESARO's CEO Discusses Q1 2014 Results - Earnings Call Transcript

Is Biotech in a Bubble? The Bear Case Explained

Biotech IPOs provide some powerful indications...

Why 2014 May Be a Big Year for Opko Health, Inc.

Opko's (OPK) has a number of catalysts this year that could have a big impact on its biggest investor, Philip Frost; including a Tesaro's (TSRO) potential FDA filing for Rolapitant.

Myriad Genetics Inks HRD Alliance with Tesaro - Analyst Blog

3 Stocks to Get on Your Watchlist

SodaStream, Cisco, and Opko Health are this week's must-watch stocks.

Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal

Five Prime, Bristol-Myers Squibb cut $350M immuno-oncology deal.

Did Tesaro Just Enter Yet Another Overcrowded Space?

See More Articles...